PL2528899T3 - Solwat sorafenibu z dimetylosulfotlenkiem - Google Patents

Solwat sorafenibu z dimetylosulfotlenkiem

Info

Publication number
PL2528899T3
PL2528899T3 PL11706017T PL11706017T PL2528899T3 PL 2528899 T3 PL2528899 T3 PL 2528899T3 PL 11706017 T PL11706017 T PL 11706017T PL 11706017 T PL11706017 T PL 11706017T PL 2528899 T3 PL2528899 T3 PL 2528899T3
Authority
PL
Poland
Prior art keywords
dimethyl sulphoxide
sulphoxide solvate
sorafenib dimethyl
sorafenib
solvate
Prior art date
Application number
PL11706017T
Other languages
English (en)
Inventor
Jagdev Singh Jaryal
Swargam Sathyanarayana
Rajesh Kumar Thaper
Mohan Prasad
Sachin Deorao Zade
Ajay Shankar Singh
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of PL2528899T3 publication Critical patent/PL2528899T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL11706017T 2010-01-29 2011-01-28 Solwat sorafenibu z dimetylosulfotlenkiem PL2528899T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN204DE2010 2010-01-29
EP11706017.8A EP2528899B1 (en) 2010-01-29 2011-01-28 Sorafenib dimethyl sulphoxide solvate
PCT/IB2011/050396 WO2011092663A2 (en) 2010-01-29 2011-01-28 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-n2-methylpyridine-2-carboxamide dimethyl sulphoxide solvate

Publications (1)

Publication Number Publication Date
PL2528899T3 true PL2528899T3 (pl) 2015-02-27

Family

ID=44243630

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11706017T PL2528899T3 (pl) 2010-01-29 2011-01-28 Solwat sorafenibu z dimetylosulfotlenkiem

Country Status (7)

Country Link
US (1) US8618305B2 (pl)
EP (1) EP2528899B1 (pl)
AU (1) AU2011210326B2 (pl)
CA (1) CA2788146C (pl)
PL (1) PL2528899T3 (pl)
WO (1) WO2011092663A2 (pl)
ZA (1) ZA201206297B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013175506A2 (en) * 2012-05-21 2013-11-28 Hetero Research Foundation Process for sorafenib tosylate polymorph iii
WO2014138905A1 (en) * 2013-03-14 2014-09-18 Apotex Technologies Inc. Forms of sorafenib tosylate and processes for the preparation thereof
CN104710354A (zh) * 2013-12-13 2015-06-17 江苏豪森药业股份有限公司 高纯度索拉非尼的制备方法
CN104761492A (zh) * 2014-01-03 2015-07-08 正大天晴药业集团股份有限公司 对甲苯磺酸索拉非尼的晶型及其制备方法
CN105181844A (zh) * 2015-09-11 2015-12-23 江苏嘉逸医药有限公司 一种高效液相色谱法测定甲苯磺酸索拉非尼含量和有关物质的方法
CN106841487A (zh) * 2015-12-04 2017-06-13 天津药物研究院有限公司 一种索拉非尼中杂质的检测方法及其应用
CN105651877A (zh) * 2015-12-30 2016-06-08 神威药业集团有限公司 一种索拉非尼及其有关物质的检测方法
CN109796400B (zh) * 2017-11-16 2022-07-29 四川科伦药物研究院有限公司 一种甲苯磺酸索拉菲尼晶型及其制备方法
CN108426964A (zh) * 2018-06-01 2018-08-21 青岛农业大学 一种液质联用检测水中苯乙酸含量的方法
CN109187831B (zh) * 2018-09-29 2021-08-03 云南中烟工业有限责任公司 采用gc-ms同时快速测定酒精中9种醇类化合物含量的方法
CN109613135A (zh) * 2018-12-24 2019-04-12 苏州市疾病预防控制中心 一种血中n-甲基氨甲酰加合物的快速检测方法
CN110243970B (zh) * 2019-06-28 2021-09-03 成都中医药大学 一种同时测定半夏中7种有机酸的hplc方法
CN110243969B (zh) * 2019-06-28 2021-09-03 成都中医药大学 一种同时测定虎掌南星中7种有机酸的hplc方法
CN118948825A (zh) * 2020-12-31 2024-11-15 沈阳糖化药物研究有限公司 一种用于治疗癌症的药物组合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
NZ554119A (en) 2004-09-29 2010-07-30 Bayer Schering Pharma Ag Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
KR101381454B1 (ko) 2004-09-29 2014-04-04 바이엘 인텔렉쳐 프로퍼티 게엠베하 열역학적으로 안정한 형태의 bay 43-9006 토실레이트
KR101335932B1 (ko) 2005-03-07 2013-12-04 바이엘 헬스케어 엘엘씨 암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
CN101611007A (zh) * 2006-12-20 2009-12-23 先灵公司 新颖的jnk抑制剂
CA2698795C (en) 2007-09-10 2016-04-19 Cipla Limited Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
WO2009054004A2 (en) 2007-10-22 2009-04-30 Natco Pharma Limited Process for the preparation of sorafenib
WO2009092070A1 (en) * 2008-01-17 2009-07-23 Sicor Inc. Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof
WO2009106825A1 (en) 2008-02-27 2009-09-03 Cipla Limited Polymorphs of sorafenib and salts thereof
EP2142507A1 (en) 2008-03-06 2010-01-13 Sicor, Inc. Process for the preparation of sorafenib and salts thereof

Also Published As

Publication number Publication date
WO2011092663A2 (en) 2011-08-04
CA2788146A1 (en) 2011-08-04
AU2011210326B2 (en) 2014-10-09
WO2011092663A3 (en) 2011-12-29
EP2528899B1 (en) 2014-10-15
CA2788146C (en) 2014-11-25
US20130210865A1 (en) 2013-08-15
ZA201206297B (en) 2013-06-26
EP2528899A2 (en) 2012-12-05
US8618305B2 (en) 2013-12-31
AU2011210326A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
ZA201206297B (en) Sorafenib dimethyl sulphoxide solvate
IL222646A0 (en) N3-substituted -n1-sulfonyl-5-fluoropyrimidinone derivatives
PT2536710T (pt) Derivados de piperidina
ZA201209117B (en) Tetrahydro-pyrido-pyrimidine derivatives
EP2634188A4 (en) FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
ZA201300032B (en) Tetrahydrocarboline derivative
PL2640598T3 (pl) Izolator sekcyjny
EP2561795A4 (en) PROBE
GB201005624D0 (en) Probe
GB2490849B (en) Di-aspirin derivatives
ZA201303887B (en) 2-carboxamide-4-piperazinyl-benzofuran derivative
EP2633796A4 (en) PROBE
SI2628733T1 (sl) Derivati acilbenzena
HU1000243D0 (en) 8-hidroxy-quinoline derivatives
PL2402077T3 (pl) Zespół izolatora
EP2653090A4 (en) PROBE
EP2522269A4 (en) PROBE
AU4803P (en) Reliance Fragaria xananassa
ZA201209248B (en) Amido-tropane derivatives
IL220983A0 (en) 2-aldoximino-5-fluoropyrimidine derivatives
GB201021329D0 (en) Early breakout
HU3950U (en) Movable building for bats
GB201005840D0 (en) Multi-catch pro
GB201016287D0 (en) CV Optimisation
GB201019863D0 (en) Structures